ShockWave Medical, Inc. SWAV
Set alert
334.75 0.00 0.00%
At close · May 30
334.75 Day range 334.90
52-week range unavailable
- Open
- 334.85
- Prev close
- 334.75
- Mkt cap
- 12.57B
- Vol
- 3.95M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 334.75
- High
- 334.90
- Forward P/E
- 55.70
- Beta
- 0.88
- Short ratio
- 2.24
- Inst. own
- 98.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 6, 2024
- 50-d avg
- 326.86
- 200-d avg
- 241.38
- 1y target
- 324.27
Analyst view
Consensus: hold
Hold
Price target (mean) 324.27 -3.1% downside
Now 334.75
- Target (low)
- 250.00
- Target (mean)
- 324.27
- Target (high)
- 348.42
Recommendation trend
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.18 | 1.15 – 1.22 | 0.76 | +55.3% | 223.80M | +24.2% | 2 |
| Next quarter | 1.25 | 1.18 – 1.33 | 0.92 | +35.9% | 234.40M | 0.0% | 2 |
| Current year | 5.09 | 4.93 – 5.25 | 3.85 | +32.2% | 917.40M | +25.6% | 2 |
| Next year | 6.01 | 5.63 – 6.39 | 5.09 | +18.1% | 1.13B | +23.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2023 | Leerink Partners | Initiated | — | Outperform |
| Sep 28, 2023 | UBS | Initiated | — | Neutral |
| Aug 9, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 7, 2023 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 7, 2023 | Needham | Maintained | Buy | Buy |
| Jul 9, 2023 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| May 8, 2023 | Deutsche Bank | Maintained | — | Buy |
| May 8, 2023 | Needham | Maintained | — | Buy |
| May 8, 2023 | Canaccord Genuity | Maintained | — | Buy |
| May 8, 2023 | Wells Fargo | Maintained | — | Equal-Weight |
| May 8, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| May 8, 2023 | Piper Sandler | Maintained | — | Overweight |
| May 8, 2023 | Oppenheimer | Reiterated | — | Underperform |
| Apr 10, 2023 | Needham | Maintained | — | Buy |
| Apr 10, 2023 | B of A Securities | Maintained | — | Buy |
| Mar 14, 2023 | Needham | Initiated | — | Buy |
| Feb 16, 2023 | Canaccord Genuity | Maintained | — | Buy |
| Feb 16, 2023 | Wells Fargo | Maintained | — | Equal-Weight |
| Jan 25, 2023 | Piper Sandler | Maintained | — | Overweight |
| Jan 5, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Dec 11, 2022 | Wells Fargo | Downgrade | Overweight | Equal-Weight |
| Nov 7, 2022 | Wells Fargo | Maintained | — | Overweight |
| Oct 10, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Sep 5, 2022 | Oppenheimer | Downgrade | Perform | Underperform |
| Aug 28, 2022 | Piper Sandler | Maintained | — | Overweight |
| Aug 8, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| Aug 8, 2022 | Piper Sandler | Maintained | — | Overweight |
| Aug 8, 2022 | Wells Fargo | Maintained | — | Overweight |
| Jul 14, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |
| May 9, 2022 | Morgan Stanley | Maintained | — | Equal-Weight |